Eton Pharmaceuticals Inc. (ETON) Reports Q1 EPS of $0.19

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.19, versus ($0.50) reported last year. Revenue for the quarter came in at $11.9 million, versus $99 thousand reported last year.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Wells Fargo upgrades S&P 500 Industrials to favorable
• Baird lowers Ryder to Neutral, warning consensus forecasts are too high
• UBS names top European chip stocks to watch ahead of Q3 2026 earnings season